title: Pustular Skin Reaction to Tumor Necrosis Factor Alpha Antagonists in Patients with Inflammatory Bowel Diseases.
authors.affiliation: *Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Unità Operativa di Dermatologia, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy †Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Medicina Interna, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy.
authors.forename: Angelo V
authors.initials: AV
authors.lastname: Marzano
authors.forename: Simona
authors.initials: S
authors.lastname: Tavecchio
authors.forename: Emilio
authors.initials: E
authors.lastname: Berti
authors.forename: Carlo
authors.initials: C
authors.lastname: Gelmetti
authors.forename: Massimo
authors.initials: M
authors.lastname: Cugno
mesh_terms: D000068879:Adalimumab / Q000009:adverse effects; D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D002990:Clobetasol / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab / Q000009:adverse effects; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D012867:Skin / Q000473:pathology*; D012871:Skin Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D002990:Clobetasol; D000069285:Infliximab; D000068879:Adalimumab; D008775:Methylprednisolone